Alzheimer's disease: Newly found peptide offers hope of early test and better treatment

Researchers in Japan have detected a peptide in cerebrospinal fluid (CSF) that can show whether a person is developing Alzheimer's disease. Measuring the level of this peptide could show that the disease process has started, long before any serious damage is done to the brain.

If you want to include this story in your blog, copy and paste this formatted text: